Morning Market Losers By: Benzinga via Benzinga July 28, 2015 at 09:51 AM EDT Immunomedics, Inc. (NASDAQ: IMMU) tumbled 46.63 percent to $1.98 following news from the company's licensing partner UCB that Phase ... Read More >> Related Stocks: Amkor Technology Audiocodes Ltd Baidu.com SP ADR Commvault Systems Immunomedics Inc Radware Ltd